Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

4.60
Delayed Data
As of Jul 21
 -0.62 / -11.88%
Today’s Change
1.97
Today|||52-Week Range
5.78
+113.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash77.5M68.0M61.4M46.8M
 
 
 
 
 
Short Term Investment Cash42.3M-9.5M-6.6M-14.1M
 
 
 
 
 
Cash & Short Term Investments77.5M68.0M61.4M46.8M
 
 
 
 
 
 
ReceivablesReceivables1.3M3.9M2.9M7.7M
 
 
 
 
 
 
InventoriesInventories5.5M7.4M16.2M33.1M
 
 
 
 
 
 
Current AssetsPrepaid Expenses------1.5M
 
 
Other Current Assets1.4M1.3M1.4M--
 
 
 
 
Current Assets85.8M80.5M81.8M89.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross9.9M23.3M33.9M35.4M
 
 
 
 
 
Depreciation-7.4M-8.2M-9.6M-11.7M
 
 
 
 
 
Other Assets2.3M1.8M2.3M4.2M
 
 
 
 
 
Total Assets90.5M97.5M109.0M119.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.4M10.4M8.4M5.8M
 
 
 
 
 
Short Term Debt13.0K0.000.000.00
 
 
Accrued Expenses4.4M3.9M7.6M4.6M
 
 
 
 
 
Other Current Liabilities15.9M22.3M43.3M51.1M
 
 
 
 
 
Other Liabilities22.2M37.3M57.6M62.9M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities347.0K1.1M1.4M1.6M
 
 
 
 
 
Total Liabilities22.8M38.4M59.0M65.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock1.0K2.0K2.0K2.0K
 
 
 
 
 
Common Equity67.7M59.0M50.1M53.6M
 
 
 
 
 
Total Shareholder Equity67.7M59.0M50.1M53.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding25.6M27.6M33.8M44.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.